Dorsey Asset Management LLC lessened its stake in Danaher Corporation (NYSE:DHR – Free Report) by 3.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 827,520 shares of the conglomerate’s stock after selling 33,330 shares during the quarter. Danaher accounts for approximately 16.5% of Dorsey Asset Management LLC’s portfolio, making the stock its 2nd biggest position. Dorsey Asset Management LLC owned approximately 0.12% of Danaher worth $189,436,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Crawford Investment Counsel Inc. purchased a new position in shares of Danaher in the 4th quarter valued at about $37,960,000. Captrust Financial Advisors boosted its stake in shares of Danaher by 2.8% in the 4th quarter. Captrust Financial Advisors now owns 268,737 shares of the conglomerate’s stock valued at $61,519,000 after buying an additional 7,268 shares during the period. &PARTNERS boosted its stake in shares of Danaher by 21.6% in the 4th quarter. &PARTNERS now owns 37,703 shares of the conglomerate’s stock valued at $8,633,000 after buying an additional 6,709 shares during the period. Manchester Global Management UK Ltd boosted its stake in shares of Danaher by 26.9% in the 4th quarter. Manchester Global Management UK Ltd now owns 230,603 shares of the conglomerate’s stock valued at $52,790,000 after buying an additional 48,846 shares during the period. Finally, ExodusPoint Capital Management LP purchased a new position in shares of Danaher in the 4th quarter valued at about $8,783,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
DHR stock opened at $181.57 on Wednesday. The business has a 50 day moving average price of $180.54 and a 200 day moving average price of $203.94. The stock has a market cap of $128.51 billion, a price-to-earnings ratio of 35.12, a PEG ratio of 2.31 and a beta of 0.81. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s payout ratio is presently 30.95%.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on DHR. Robert W. Baird decreased their price objective on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. Argus decreased their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Morgan Stanley decreased their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group restated a “buy” rating and set a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Finally, Wells Fargo & Company decreased their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $233.61.
View Our Latest Stock Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
